Cell-based assays in GPCR drug discovery

Sandra Siehler1

  • 1Novartis Institutes for BioMedical Research Basel, Center for Proteomic Chemistry, Novartis Pharma AG, 4002 Basel, Switzerland. sandra.siehler@novartis.com

Biotechnology Journal
|April 3, 2008
PubMed

Related Concept Videos